Posted by Michael Wonder on 14 Aug 2018
PHARMAC funding of MS drugs "restrictive & cruel"
14 August 2018 - An Australian neurologist says the way PHARMAC's criteria for continuing access to drugs for multiple sclerosis are too old, and not based on evidence.
His comments were made in response to Auckland man Brendan Rochford's funding for multiple sclerosis treatment being cut off this year, because he could not walk 500m.
Mr Rochford is required to walk the distance each year to continue getting funding for Tysabri.
